Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis.

Davey, M G; Ryan, É J; Davey, M S; Lowery, A J; Miller, N; Kerin, M J

Davey, M G; Ryan, É J; Davey, M S; Lowery, A J; Miller, N; Kerin, M J.

Afiliação

Davey MG; Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.
Ryan ÉJ; Department of Surgery, Galway University Hospitals, Galway, Ireland.
Davey MS; Department of Surgery, Galway University Hospitals, Galway, Ireland.
Lowery AJ; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.
Miller N; Department of Surgery, Galway University Hospitals, Galway, Ireland.
Kerin MJ; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland.

Br J Surg ; 108(6): 622-631, 2021 06 22.

Article em En | MEDLINE | ID: mdl-33963374

Assuntos

Antígeno B7-H1/metabolismo; Neoplasias da Mama/patologia; Biomarcadores Tumorais/metabolismo; Neoplasias da Mama/diagnóstico; Neoplasias da Mama/metabolismo; Feminino; Humanos; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígeno B7-H1 Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google